Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2023-504173-21-00Phase 4Completed
Phase 4, single-arm trial of Mydrane in cataract, sponsored by Antwerp University Hospital. Primary endpoint: Sufficient pupillary dilatation to perform surgery without mechanical dilatation. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2023-504173-21-00.